Loading…
Sharps Technology received a signed $30 million purchase order from Nephron Pharmaceuticals for 10mL and 50mL specialty copolymer prefillable syringes, covering the first 12 months of a five-year, $200 million sales agreement. The syringes will be manufactured at the West Columbia, South Carolina site being acquired from Nephron.
“Sharps Technology, Inc....received a signed $30 million purchase order from Nephron Pharmaceuticals, representing their first 12 months of syringe purchase commitments.”ir.sharpstechnology.com
Summarized from public sources; check the original articles before acting on it.